CVS・ヘルスがQ2収益を報告し 起訴にもかかわらず2025年の予測値を上げました CVS Health reported strong Q2 earnings, raising 2025 forecast despite litigation charges.

CVS・ヘルスは第2四半期の強い収入を報告し,収入は98.9億円に上ります. CVS Health reported strong second-quarter earnings, with revenue at $98.9 billion, beating predictions. 調整後の利益は 分析者の予想を上回り 株当たり1.81ドルでした Adjusted earnings topped analyst forecasts at $1.81 per share. 同社は2025年度の収益予測を1株あたり6.30ドルから6.40ドルに上げ,薬局や保険部門の成長を反映した. The company raised its 2025 earnings forecast to $6.30 to $6.40 per share, reflecting growth in its pharmacy and insurance segments. 訴訟費用による営業収益の減少にもかかわらず,CVSの株価は,そのポジティブな結果に反応して急上昇した. Despite a decline in operating income due to litigation charges, CVS's stock surged in response to the positive results.